Capital Expenditures for Labcorp Holdings (LH)
According to Labcorp Holdings's latest reported financial statements, the company's current capital expenditures (TTM) is $434.50M USD. Capital expenditures (CapEx) are cash outlays for property, plant, and equipment and other long-lived productive assets — reported on the cash flow statement under investing activities. CapEx funds future capacity (factories, data centers, software, machinery), so rising spend can signal investment in growth, while heavy CapEx reduces free cash flow available to shareholders. We display CapEx as a positive amount (the absolute cash outflow); compare with revenue to gauge capital intensity and with total assets for the asset-base context.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingCapital ExpendituresSwitch metric
Latest period
$434.50M
YoY change
-11.3%
5Y CAGR
+2.6%
Peak year (2024)
$489.90M
Cumulative capital expenditures
$6.71B
CapEx history chart for Labcorp Holdings (LH) from 1989 to 2025
CapEx history table for Labcorp Holdings (LH) from 1989 to 2025
| Fiscal year | Period ended | Reported | Capital Expenditures | YoY |
|---|---|---|---|---|
| 2025 | $434.50M | -11.3% | ||
| 2024 | $489.90M | +8.0% | ||
| 2023 | $453.60M | -5.9% | ||
| 2022 | $481.90M | +4.7% | ||
| 2021 | $460.40M | +20.6% | ||
| 2020 | $381.70M | -4.6% | ||
| 2019 | $400.20M | +5.4% | ||
| 2018 | $379.80M | +20.4% | ||
| 2017 | $315.40M | +13.1% | ||
| 2016 | $278.90M | +9.0% | ||
| 2015 | $255.80M | +25.7% | ||
| 2014 | $203.50M | +0.6% | ||
| 2013 | $202.20M | +14.7% | ||
| 2012 | $176.30M | +21.0% | ||
| 2011 | $145.70M | +15.2% | ||
| 2010 | $126.50M | +10.3% | ||
| 2009 | $114.70M | -26.8% | ||
| 2008 | $156.70M | +9.4% | ||
| 2007 | $143.30M | +23.0% | ||
| 2006 | $116.50M | +24.5% | ||
| 2005 | $93.60M | -1.5% | ||
| 2004 | $95.00M | +13.6% | ||
| 2003 | $83.60M | +12.5% | ||
| 2002 | $74.30M | -15.7% | ||
| 2001 | $88.10M | +58.7% | ||
| 2000 | $55.50M | -20.0% | ||
| 1999 | $69.40M | -15.8% | ||
| 1998 | $82.40M | +138.8% | ||
| 1997 | $34.50M | -36.2% | ||
| 1996 | $54.10M | -28.2% | ||
| 1995 | $75.40M | +54.2% | ||
| 1994 | $48.90M | +45.5% | ||
| 1993 | $33.60M | -9.7% | ||
| 1992 | $37.20M | +39.8% | ||
| 1991 | $26.60M | +78.5% | ||
| 1990 | $14.90M | -37.1% | ||
| 1989 | $23.70M | — |
CapEx values are taken from Labcorp Holdings's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of Labcorp Holdings (LH) capital expenditures is $434.50M – declined 11.3% year-over-year.
Labcorp Holdings capital expenditures compound annual growth for the 2020–2025 (5 years) window is +2.6%, with the latest reading among the more recent periods of the dataset.
Labcorp Holdings capital expenditures peaked at $489.90M in 2024; the latest annual figure is $434.50M in 2025 (11.3% below peak).
The dataset's maximum capital expenditures sits at $489.90M (2024); the minimum reading of $14.90M dates to 1990.
Labcorp Holdings (LH) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $3.87B.
Labcorp Holdings Capital Expenditures by Year
Labcorp Holdings Capital Expenditures 2025: $434.50M
Labcorp Holdings capital expenditures in 2025 was $434.50M, declined 11.3% below 2024.
Labcorp Holdings Capital Expenditures 2024: $489.90M
Labcorp Holdings capital expenditures in 2024 was $489.90M, grew 8.0% from 2023. This figure represents the highest annual value in the available history.
Labcorp Holdings Capital Expenditures 2023: $453.60M
Labcorp Holdings capital expenditures in 2023 was $453.60M, declined 5.9% below 2022.
Labcorp Holdings Capital Expenditures 2022: $481.90M
Labcorp Holdings capital expenditures in 2022 was $481.90M, edged up 4.7% from 2021.
Labcorp Holdings Capital Expenditures 2021: $460.40M
Labcorp Holdings capital expenditures in 2021 was $460.40M.
See more financial history for Labcorp Holdings (LH).
Sector peers — CapEx
Companies in the same sector as Labcorp Holdings, ranked by their latest capital expenditures.
| Company | Capital Expenditures | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $90.11B | Healthcare |
| Eli Lilly and Company (LLY) | $7.84B | Healthcare |
| Johnson & Johnson (JNJ) | $4.83B | Healthcare |
| Merck & Co., Inc. (MRK) | $4.11B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $3.62B | Healthcare |
| AstraZeneca PLC (AZN) | $2.81B | Healthcare |
| Amgen Inc. (AMGN) | $1.86B | Healthcare |
| AbbVie Inc. (ABBV) | $1.21B | Healthcare |
Frequently asked questions
What is Labcorp Holdings's capital expenditures?
- Latest reported capital expenditures for Labcorp Holdings (LH) is $434.50M (period ending December 31, 2025).
How has Labcorp Holdings capital expenditures changed year-over-year?
- Labcorp Holdings (LH) capital expenditures changed -11.3% year-over-year on the latest annual filing.
What is the long-term growth rate of Labcorp Holdings capital expenditures?
- Labcorp Holdings (LH) capital expenditures compound annual growth rate is +2.6% over the most recent 5 years available.
When did Labcorp Holdings capital expenditures hit its highest annual value?
- Labcorp Holdings capital expenditures reached its highest annual value of $489.90M in 2024.
What was Labcorp Holdings capital expenditures in 2024?
- Labcorp Holdings (LH) capital expenditures in 2024 was $489.90M.
What was Labcorp Holdings capital expenditures in 2025?
- Labcorp Holdings (LH) capital expenditures in 2025 was $434.50M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
LH Overview
Company profile, financial tools, and key metrics
LH Revenue Counter
Earns $442.41 every second. See per minute, hour, and day.
LH Earnings Counter
Earns $27.79 per second net profit. See per minute, hour, and day.
LH Economic Scale
Exceeds West Bank and Gaza's GDP. Compare with world economies.
LH What If Invested
What if you had invested $1,000? See historical returns from any date.
LH How It Makes Money
Discover visual breakdown of $13.95B in revenue — where it comes from and where it goes.
LH Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
LH Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
LH Daily Price Character
Balanced · 47.4% historical win rate (green days). Streaks & record days.
LH Buybacks
2.17% TTM buyback yield. Shareholder yield & SBC comparison.
LH Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.
LH Dividend Profile
Yield: 1.12%. Safety: 4/6. See full history.
LH Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
LH Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.